DBOCX
Price
$21.83
Change
-$0.07 (-0.32%)
Updated
Apr 17 closing price
Net Assets
258.17M
RLBFX
Price
$33.02
Change
-$0.08 (-0.24%)
Updated
Apr 17 closing price
Net Assets
225.48B
Ad is loading...

DBOCX vs RLBFX

Header iconDBOCX vs RLBFX Comparison
Open Charts DBOCX vs RLBFXBanner chart's image
BNY Mellon Balanced Opportunity C
Price$21.83
Change-$0.07 (-0.32%)
VolumeN/A
Net Assets258.17M
American Funds American Balanced R5
Price$33.02
Change-$0.08 (-0.24%)
VolumeN/A
Net Assets225.48B
DBOCX vs RLBFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DBOCX vs. RLBFX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBOCX is a Buy and RLBFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 225B vs. DBOCX (258M). RLBFX pays higher dividends than DBOCX: RLBFX (2.26) vs DBOCX (0.44). DBOCX was incepted earlier than RLBFX: DBOCX (21 years) vs RLBFX (23 years). DBOCX (2.06) is less costly to investors than RLBFX (0.30). RLBFX is a more actively managed with annual turnover of: 171.00 vs. DBOCX (46.25). RLBFX has a lower initial minimum investment than DBOCX: RLBFX (250) vs DBOCX (1000). RLBFX annual gain was more profitable for investors over the last year : 2.88 vs. DBOCX (-2.29). RLBFX return over 5 years is better than : 33.40 vs. DBOCX (7.15).
DBOCXRLBFXDBOCX / RLBFX
Total Expense Ratio1.900.30633%
Annual Report Gross Expense Ratio2.060.30687%
Fund Existence21 years23 years-
Gain YTD-6.290-3.617174%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets258M225B0%
Annual Yield % from dividends0.442.2620%
Returns for 1 year-2.292.88-79%
Returns for 3 years-3.7210.75-35%
Returns for 5 years7.1533.4021%
Returns for 10 years2.8347.016%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FANUY12.050.38
+3.26%
Fanuc Corporation
ELTP0.42N/A
+0.24%
Elite Pharmaceuticals, Inc.
HYSNY3.27N/A
N/A
Hysan Development Co., Ltd.
AAIGF6.88-0.01
-0.09%
AIA Group, Ltd.
SOUHY8.52-0.07
-0.81%
South32 Ltd.